Literature DB >> 20151161

Risk factors in community-acquired urinary tract infections caused by ESBL-producing bacteria in children.

Rezan Topaloglu1, Ilkay Er, Bahar Guciz Dogan, Yelda Bilginer, Fatih Ozaltin, Nesrin Besbas, Seza Ozen, Aysin Bakkaloglu, Deniz Gur.   

Abstract

In this study, risk factors were investigated in children with community-acquired urinary tract infections (UTI) caused by extended-spectrum beta-lactamases (ESBL)-producing E. coli or Klebsiella spp. One hundred and fifty-five patients were diagnosed with ESBL-positive UTI (case group) in the outpatient clinics of Hacettepe University Children's Hospital between 1 January 2004 and 31 December 2006. A control group, 155 out of 4,105 children, was matched by age and sex among children with ESBL-negative UTI. A total of 310 patients' files were evaluated retrospectively. As regards the symptoms of UTI, no statistical differences were seen between the two groups. Although the most frequently isolated microorganism was E. coli in both groups, Klebsiella spp. was found to be more frequent in those diagnosed with ESBL(+) UTI (p < 0.001). Having an underlying disease and hospitalization, infections, and use of antibiotics within the last 3 months were found to be potential risk factors (p < 0.001). With conditional logistic regression analysis, having an underlying disease and hospitalization within the last 3 months were identified as independent risk factors for ESBL(+) UTI. In conclusion, the recognition of risk factors for UTI, caused by ESBL(+) bacteria in children, may aid in the identification of high-risk cases and may enable proper management of these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20151161     DOI: 10.1007/s00467-009-1431-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  27 in total

1.  Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.

Authors:  R Colodner; W Rock; B Chazan; N Keller; N Guy; W Sakran; R Raz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

2.  Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation.

Authors:  D A Schiappa; M K Hayden; M G Matushek; F N Hashemi; J Sullivan; K Y Smith; D Miyashiro; J P Quinn; R A Weinstein; G M Trenholme
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

3.  Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.

Authors:  Selçuk Yüksel; Burcu Oztürk; Asli Kavaz; Z Birsin Ozçakar; Banu Acar; Haluk Güriz; Derya Aysev; Mesiha Ekim; Fatoş Yalçinkaya
Journal:  Int J Antimicrob Agents       Date:  2006-09-26       Impact factor: 5.283

4.  Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Authors:  Javier Ena; Francisco Arjona; Carmen Martínez-Peinado; Maria Del Mar López-Perezagua; Concepción Amador
Journal:  Urology       Date:  2006-12       Impact factor: 2.649

5.  Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.

Authors:  Bin Du; Yun Long; Hongzhong Liu; Dechang Chen; Dawei Liu; Yingchun Xu; Xiuli Xie
Journal:  Intensive Care Med       Date:  2002-10-17       Impact factor: 17.440

6.  Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

Authors:  N Woodford; M E Ward; M E Kaufmann; J Turton; E J Fagan; D James; A P Johnson; R Pike; M Warner; T Cheasty; A Pearson; S Harry; J B Leach; A Loughrey; J A Lowes; R E Warren; D M Livermore
Journal:  J Antimicrob Chemother       Date:  2004-09-03       Impact factor: 5.790

7.  Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.

Authors:  David L Paterson; Wen-Chien Ko; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Robert A Bonomo; Louis B Rice; Marilyn M Wagener; Joseph G McCormack; Victor L Yu
Journal:  Clin Infect Dis       Date:  2004-06-08       Impact factor: 9.079

8.  Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.

Authors:  Esther Calbo; Verónica Romaní; Mariona Xercavins; Lucía Gómez; Carolina Garcia Vidal; Salvador Quintana; Jordi Vila; Javier Garau
Journal:  J Antimicrob Chemother       Date:  2006-02-21       Impact factor: 5.790

9.  Antibiotic resistance pattern in uropathogens.

Authors:  V Gupta; A Yadav; R M Joshi
Journal:  Indian J Med Microbiol       Date:  2002 Apr-Jun       Impact factor: 0.985

10.  Risk factors in community-acquired/onset urinary tract infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Authors:  E Yilmaz; H Akalin; S Ozbey; Y Kordan; M Sinirtaş; E Gürcüoglu; C Ozakin; Y Heper; R Mistik; S Helvaci
Journal:  J Chemother       Date:  2008-10       Impact factor: 1.714

View more
  26 in total

Review 1.  Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threat.

Authors:  Paul J Lukac; Robert A Bonomo; Latania K Logan
Journal:  Clin Infect Dis       Date:  2015-01-16       Impact factor: 9.079

2.  Spread of CTX-M-15 extended-spectrum β-lactamase-producing Escherichia coli isolates through household contact and plasmid transfer.

Authors:  Yasuko Kojima; Sohei Harada; Kotaro Aoki; Yoshikazu Ishii; Tomoka Sawa; Kei Hasegawa; Tsutomu Saji; Keizo Yamaguchi; Kazuhiro Tateda
Journal:  J Clin Microbiol       Date:  2014-02-19       Impact factor: 5.948

3.  Low relapse rate of urinary tract infections from extended-spectrum beta-lactamase-producing bacteria in young children.

Authors:  Hye Sun Hyun; Ji Hye Kim; Myung Hyun Cho; Eujin Park; Il-Soo Ha; Hae Il Cheong; Hee Gyung Kang
Journal:  Pediatr Nephrol       Date:  2019-07-04       Impact factor: 3.714

4.  Trends and risk factors of extended-spectrum beta-lactamase urinary tract infection in Chinese children: a nomogram is built and urologist should act in time.

Authors:  Jiandong Lu; Lin Wang; Yi Wei; Shengde Wu; Guanghui Wei
Journal:  Transl Pediatr       Date:  2022-06

5.  Urinary tract infection in infants caused by extended-spectrum beta-lactamase-producing Escherichia coli: comparison between urban and rural hospitals.

Authors:  Ming-Fang Cheng; Wan-Ling Chen; I-Fei Huang; Jung-Ren Chen; Yee-Hsuan Chiou; Yao-Shen Chen; Susan Shin-Jung Lee; Wan-Yu Hung; Chih-Hsin Hung; Jiun-Ling Wang
Journal:  Pediatr Nephrol       Date:  2016-03-14       Impact factor: 3.714

6.  Extended-spectrum β-lactamase-producing bacteria causing community-acquired urinary tract infections in children.

Authors:  Orli Megged
Journal:  Pediatr Nephrol       Date:  2014-04-05       Impact factor: 3.714

7.  Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study.

Authors:  Basima A Almomani; Wail A Hayajneh; Abeer M Ayoub; Mera A Ababneh; Miral A Al Momani
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

8.  Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.

Authors:  Seung Beom Han; Sung Chul Lee; Soo Young Lee; Dae Chul Jeong; Jin Han Kang
Journal:  BMC Infect Dis       Date:  2015-10-13       Impact factor: 3.090

9.  Third-generation cephalosporin-resistant urinary tract infections in children presenting to the paediatric emergency department.

Authors:  Kristopher T Kang; Karen Ng; Jennifer Kendrick; Peter Tilley; Joseph Ting; Shahrad Rassekh; Srinivas Murthy; Ashley Roberts
Journal:  Paediatr Child Health       Date:  2019-02-05       Impact factor: 2.253

10.  Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.

Authors:  Arne Søraas; Arnfinn Sundsfjord; Irene Sandven; Cathrine Brunborg; Pål A Jenum
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.